Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brett Hauber

Showing results (41-50 of 165) with videos related to

Pageof 17
Sort By:
The Patient|April 2, 2026
Putting Patient Voices at the Heart of Healthcare Decisions: The UNIFIED Public-Private ProjectEsther W de Bekker-Grob, Jorien Veldwijk, Bianca Pop, et al.
Pharmacoeconomics|November 11, 2016
Weighing Clinical Evidence Using Patient Preferences: An Application of Probabilistic Multi-Criteria Decision AnalysisHenk Broekhuizen, Maarten J IJzerman, A Brett Hauber, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|October 24, 2017
Improving the quality of discrete-choice experiments in health: how can we assess validity and reliability?Ellen M Janssen, Deborah A Marshall, A Brett Hauber, et al.
Frontiers in Medicine|March 26, 2021
Patient Preferences to Assess Value IN Gene Therapies: Protocol Development for the PAVING Study in HemophiliaEline van Overbeeke, Brett Hauber, Sissel Michelsen, et al.
Pharmacoeconomics - Open|February 17, 2025
Do We Understand Unmet Need? A Proposal to Use Length-Of-Life Equivalent (LOLE) as a Patient-Centric Measure of Unmet NeedKevin Marsh, Robert F Reynolds, Linda Nelsen, et al.
Current Medical Research and Opinion|May 16, 2014
Relative importance of benefits and risks associated with antithrombotic therapies for acute coronary syndrome: patient and physician perspectivesZhong Yuan, Bennett Levitan, Paul Burton, et al.
The Journal of Dermatological Treatment|October 7, 2020
Quantifying patient preferences for systemic atopic dermatitis treatments using a discrete-choice experimentMarco Boeri, Jessie Sutphin, Brett Hauber, et al.
Patient Preference and Adherence|August 3, 2019
From drug-delivery device to disease management tool: a study of preferences for enhanced features in next-generation self-injection devicesMarco Boeri, Boglarka Szegvari, Brett Hauber, et al.
The Journal of Dermatological Treatment|January 7, 2021
Impact of clinical and demographic characteristics on patient preferences for psoriasis treatment features: Results from a discrete-choice experiment in a multicountry studyMarco Boeri, Daniel Saure, Christopher Schuster, et al.
Therapeutic Innovation & Regulatory Science|October 28, 2020
Quantitative Benefit-Risk Assessment: State of the Practice Within IndustryMeredith Y Smith, Janine van Til, Rachael L DiSantostefano, et al.
Pageof 17

Showing results (41-50 of 165) with videos related to

Sort By:
Pageof 17
The Patient|April 2, 2026
Putting Patient Voices at the Heart of Healthcare Decisions: The UNIFIED Public-Private ProjectEsther W de Bekker-Grob, Jorien Veldwijk, Bianca Pop, et al.
Pharmacoeconomics|November 11, 2016
Weighing Clinical Evidence Using Patient Preferences: An Application of Probabilistic Multi-Criteria Decision AnalysisHenk Broekhuizen, Maarten J IJzerman, A Brett Hauber, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|October 24, 2017
Improving the quality of discrete-choice experiments in health: how can we assess validity and reliability?Ellen M Janssen, Deborah A Marshall, A Brett Hauber, et al.
Frontiers in Medicine|March 26, 2021
Patient Preferences to Assess Value IN Gene Therapies: Protocol Development for the PAVING Study in HemophiliaEline van Overbeeke, Brett Hauber, Sissel Michelsen, et al.
Pharmacoeconomics - Open|February 17, 2025
Do We Understand Unmet Need? A Proposal to Use Length-Of-Life Equivalent (LOLE) as a Patient-Centric Measure of Unmet NeedKevin Marsh, Robert F Reynolds, Linda Nelsen, et al.
Current Medical Research and Opinion|May 16, 2014
Relative importance of benefits and risks associated with antithrombotic therapies for acute coronary syndrome: patient and physician perspectivesZhong Yuan, Bennett Levitan, Paul Burton, et al.
The Journal of Dermatological Treatment|October 7, 2020
Quantifying patient preferences for systemic atopic dermatitis treatments using a discrete-choice experimentMarco Boeri, Jessie Sutphin, Brett Hauber, et al.
Patient Preference and Adherence|August 3, 2019
From drug-delivery device to disease management tool: a study of preferences for enhanced features in next-generation self-injection devicesMarco Boeri, Boglarka Szegvari, Brett Hauber, et al.
The Journal of Dermatological Treatment|January 7, 2021
Impact of clinical and demographic characteristics on patient preferences for psoriasis treatment features: Results from a discrete-choice experiment in a multicountry studyMarco Boeri, Daniel Saure, Christopher Schuster, et al.
Therapeutic Innovation & Regulatory Science|October 28, 2020
Quantitative Benefit-Risk Assessment: State of the Practice Within IndustryMeredith Y Smith, Janine van Til, Rachael L DiSantostefano, et al.
Pageof 17